Tag Archives: Peter Goldschmidt

SCHOTT Pharma Extends CEO Andreas Reisse’s Tenure to 2026 While Appointing Reinhard Mayer as CFO

(IN BRIEF) SCHOTT Pharma’s Supervisory Board has prolonged CEO Andreas Reisse’s mandate until April 2026, reflecting his pivotal role in driving the company’s emergence as a world-leading manufacturer of pharmaceutical containment and delivery systems. CFO Dr. Almuth Steinkühler will step … Read the full press release

Peter Goldschmidt succeeded Claudio Albrecht as the Chief Executive Officer of STADA Arzneimittel AG

Goldschmidt: “I look forward to working with the highly experienced team at STADA and continuing the Group’s long-term growth” Supervisory Board Chairman von Au: “Goldschmidt is the right man that STADA needs to ensure the Group successfully retains its strong … Read the full press release

Sandoz announced US market introduction of its generic version of Pulmicort Respules®

Princeton, New Jersey, 30-7-2015 — /EuropaWire/ — Sandoz today announced the US market introduction of its budesonide inhalation suspension, a generic version of Pulmicort Respules® (budesonide) inhalation suspension 1 mg strength by AstraZeneca LP. Sandoz’s budesonide inhalation suspension product is indicated … Read the full press release